WallStSmart

Acadia Healthcare Company Inc (ACHC)vsDaVita HealthCare Partners Inc (DVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 316% more annual revenue ($14.01B vs $3.37B). DVA leads profitability with a 6.0% profit margin vs -33.4%. DVA appears more attractively valued with a PEG of 0.45. DVA earns a higher WallStSmart Score of 70/100 (B).

ACHC

Hold

47

out of 100

Grade: D+

Growth: 3.3Profit: 4.0Value: 7.0Quality: 4.5
Piotroski: 4/9Altman Z: 0.29

DVA

Strong Buy

70

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACHCUndervalued (+83.0%)

Margin of Safety

+83.0%

Fair Value

$91.60

Current Price

$28.36

$63.24 discount

UndervaluedFair: $91.60Overvalued
DVAOvervalued (-13.0%)

Margin of Safety

-13.0%

Fair Value

$127.66

Current Price

$181.55

$53.89 premium

UndervaluedFair: $127.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

DVA5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

EPS GrowthGrowth
55.8%10/10

Earnings expanding 55.8% YoY

Debt/EquityHealth
-14.0910/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Areas to Watch

ACHC4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.303/10

Elevated debt levels

Return on EquityProfitability
-56.5%2/10

ROE of -56.5% — below average capital efficiency

Revenue GrowthGrowth
-0.4%2/10

Revenue declined 0.4%

EPS GrowthGrowth
-63.6%2/10

Earnings declined 63.6%

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACHC

The strongest argument for ACHC centers on Price/Book. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bull Case : DVA

The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bear Case : ACHC

The primary concerns for ACHC are Debt/Equity, Return on Equity, Revenue Growth.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

ACHC profiles as a turnaround stock while DVA is a value play — different risk/reward profiles.

DVA carries more volatility with a beta of 0.83 — expect wider price swings.

DVA is growing revenue faster at 5.2% — sustainability is the question.

DVA generates stronger free cash flow (320M), providing more financial flexibility.

Bottom Line

DVA scores higher overall (70/100 vs 47/100). ACHC offers better value entry with a 83.0% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acadia Healthcare Company Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.

Visit Website →

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?